MHRA Class 3 Medicines Recall: Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection
MHRA Class 3 Medicines Recall: Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection Drug Alert Number: EL(25)A/08 Date issued: 03 March 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall notice for: Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection DMRC reference [...]
The post MHRA Class 3 Medicines Recall: Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection appeared first on Community Pharmacy England.
Recent Comments